2019 annual financial data
Zevra Therapeutics 2019 Operating margin
Direct answer
Operating margin was -158.4%.
Operating income was -20,337,000 USD and net income was -24,522,000 USD.
Operating cash flow was -23,737,000 USD.
Get free Zevra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,839,000 USD
- Operating income
- -20,337,000 USD
- Net income
- -24,522,000 USD
- Operating cash flow
- -23,737,000 USD